Publications by authors named "Marc Aprahamian"

Claim this Profile
A
Antitumor Effects of Lidocaine on Human Breast Cancer Cells: An and Experimental Trial.
Thiên-Nga Chamaraux-Tran, Carole Mathelin, Marc Aprahamian, Girish P Joshi, Catherine Tomasetto

Anticancer Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and reliability of pancreatic cancer staging using a new confocal non-fluorescent microscopy probe: a double-blind study in rats.
Cherif Akladios, Vivian De Ruijter, Sylvana Perretta, Marc Aprahamian, Mihaela Ignat

Surg Endosc· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival variability of controls and definition of imaging endpoints for longitudinal follow-up of pancreatic ductal adenocarcinoma in rats.
Cherif Akladios, Mihaela Ignat, Didier Mutter, Marc Aprahamian

J Cancer Res Clin Oncol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and Characterization of a Novel Cell Line, ASAN-PaCa, Derived From Human Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of the Pancreas.
Anette Heller, Assia L Angelova, Sonja Bauer, Svitlana P Grekova, Marc Aprahamian

Pancreas· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virotherapy of digestive tumors with rodent parvovirus: overview and perspectives.
Cherif Akladios, Marc Aprahamian

Expert Opin Biol Ther· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and development of a robotized system coupled to µCT imaging for intratumoral drug evaluation in a HCC mouse model.
Gaétan Bour, Fernand Martel, Laurent Goffin, Bernard Bayle, Jacques Gangloff, Marc Aprahamian

PLoS One· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myo-inositol trispyrophosphate-mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy.
Zahary Raykov, Svitlana P Grekova, Gaétan Bour, Jean Marie Lehn, N A Giese, Marc Aprahamian

Int J Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer.
Assia L Angelova, Svitlana P Grekova, Anette Heller, Olga Kuhlmann, Esther Soyka, Marc Aprahamian

J Virol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas.
Junwei Li, Serena Bonifati, Georgi Hristov, Tiina Marttila, Séverine Valmary-Degano, Marc Aprahamian

EMBO Mol Med· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer.
Svitlana P Grekova, Marc Aprahamian, Laurent Daeffler, Barbara Leuchs, Assia Angelova

Cancer Biol Ther· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myo-InositolTrisPyroPhosphate treatment leads to HIF-1α suppression and eradication of early hepatoma tumors in rats.
Marc Aprahamian, Gaétan Bour, Chérif Y Akladios, Konstantina Fylaktakidou, Ruth Greferath

Chembiochem· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Contribution of microCT structural imaging to preclinical evaluation of hepatocellular carcinoma chemotherapeutics on orthotopic graft in ACI rats].
Cherif Youssef Akladios, Gaëtan Bour, Ginette Balboni, Didier Mutter, Jacques Marescaux, Marc Aprahamian

Bull Cancer· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune cells participate in the oncosuppressive activity of parvovirus H-1PV and are activated as a result of their abortive infection with this agent.
Svitlana Grekova, Marc Aprahamian, Nathalia Giese, Steffen Schmitt, Thomas Giese

Cancer Biol Ther· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and reliability of pancreatic cancer staging using fiberoptic confocal fluorescence microscopy in rats.
Mihaela Ignat, Marc Aprahamian, Veronique Lindner, Anaïs Altmeyer, Silvana Perretta

Gastroenterology· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studies.
Assia L Angelova, Marc Aprahamian, Ginette Balboni, Henri-Jacques Delecluse, Regina Feederle

Mol Ther· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV.
Assia L Angelova, Marc Aprahamian, Svitlana P Grekova, Amor Hajri, Barbara Leuchs

Clin Cancer Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arming parvoviruses with CpG motifs to improve their oncosuppressive capacity.
Zahari Raykov, Svetlana Grekova, Barbara Leuchs, Marc Aprahamian, Jean Rommelaere

Int J Cancer· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telomerase transcriptional targeting of inducible Bax/TRAIL gene therapy improves gemcitabine treatment of pancreatic cancer.
Séverine Wack, Soukaina Rejiba, Céline Parmentier, Marc Aprahamian, Amor Hajri

Mol Ther· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment.
Soukaina Réjiba, Séverine Wack, Marc Aprahamian, Amor Hajri

Cancer Sci· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo evaluation of a new composite mesh (10% polypropylene/90% poly-L-lactic acid) for hernia repair.
Keitaro Tanaka, Didier Mutter, Harutaka Inoue, Véronique Lindner, George Bouras, Marc Aprahamian

J Mater Sci Mater Med· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined oncolytic and vaccination activities of parvovirus H-1 in a metastatic tumor model.
Zahari Raykov, Svetlana Grekova, Angel S Galabov, Ginette Balboni, Ute Koch, Marc Aprahamian

Oncol Rep· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carrier cell-mediated delivery of oncolytic parvoviruses for targeting metastases.
Zahari Raykov, Ginette Balboni, Marc Aprahamian, Jean Rommelaere

Int J Cancer· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis